Belmont Capital, LLC Novartis Ag Transaction History
Belmont Capital, LLC
- $531 Million
- Q2 2024
A detailed history of Belmont Capital, LLC transactions in Novartis Ag stock. As of the latest transaction made, Belmont Capital, LLC holds 3,058 shares of NVS stock, worth $347,908. This represents 0.06% of its overall portfolio holdings.
Number of Shares
3,058
Previous 3,058
-0.0%
Holding current value
$347,908
Previous $295,000
10.17%
% of portfolio
0.06%
Previous 0.08%
Shares
3 transactions
Others Institutions Holding NVS
# of Institutions
1,426Shares Held
138MCall Options Held
1.48MPut Options Held
1.54M-
Dodge & Cox San Francisco, CA12.2MShares$1.39 Billion0.82% of portfolio
-
Primecap Management CO Pasadena, CA12.2MShares$1.39 Billion0.95% of portfolio
-
Morgan Stanley New York, NY7.42MShares$844 Million0.06% of portfolio
-
Dimensional Fund Advisors LP Austin, TX7.41MShares$843 Million0.21% of portfolio
-
Loomis Sayles & CO L P5.95MShares$676 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $245B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...